Literature DB >> 21377080

Remifentanil-nitroglycerin combination as an anesthetic support for ex utero intrapartum treatment (EXIT) procedure.

Alexander Ioscovich1, Ori Shen, Jean-Yves Sichel, Yishay Lajos, Dina Orkin, Reuven Bromiker, Alexander Briskin.   

Abstract

A 21 year old healthy parturient was diagnosed as having a fetus with micrognathia. She was scheduled for an ex-utero intrapartum treatment (EXIT) procedure. General anesthesia consisted of remifentanil, nitrous oxide, and midazolam. Intravenous nitroglycerin was used for uterine relaxation. This technique offered hemodynamic stability and provided uterine relaxation that may be rapidly terminated. For the fetus, it provided excellent transplacental anesthesia. Supplemental direct fetal anesthesia is recommended to prevent the rapid decline of analgesia/anesthesia that occurs after placental separation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377080     DOI: 10.1016/j.jclinane.2009.12.014

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

Review 1.  Update in fetal anesthesia for the ex utero intrapartum treatment (EXIT) procedure.

Authors:  Pornswan Ngamprasertwong; Alexander A Vinks; Anne Boat
Journal:  Int Anesthesiol Clin       Date:  2012

Review 2.  Role of anesthesiologist in ex utero intrapartum treatment procedure: A case and review of anesthetic management.

Authors:  Rajkumar Subramanian; Pallavi Mishra; Rajeshwari Subramaniam; Sumit Bansal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Apr-Jun

Review 3.  Maternal anesthesia for EXIT procedure: A systematic review of literature.

Authors:  Kamal Kumar; Cristiana Miron; Sudha Indu Singh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.